Skip to main content
. 2020 Oct 2;15:295. doi: 10.1186/s13019-020-01347-0

Table 4.

Clinical Summary of CT proven PE Patients before CPR or ECMO initiation (N = 13)

Case No. Age, years/Sex Risk classification Troponin-I, ng/mL RV/LV diameter ratio on CT Time from CT to CPR or ECMO, hours Time from shock to CPR or ECMO, hours ECMO indication Outcome
1 66/F Low < 0.02 0.8 149.8 0.0 During CPR Alive
2 30/M Submassive 0.05 1.5 61.3 0.2 During CPR Dead
3 42/M Submassive 0.05 1.6 36.8 0.6 During CPR Dead
4 46/F Submassive 0.181 1.3 4.8 0.0 Previous CPR Dead
5 60/M Submassive 0.66 2.3 2.5 0.0 During CPR Alive
6 42/M Submassive 0.172 2 5.6 1.9 Shock Dead
7 45/M Submassive 0.08 2 2.8 1.0 Shock Alive
8 72/M Submassive < 0.01 2.8 1.3 1.0 Shock Alive
9 73/M Massive < 0.02 0.9 15.2 18.3 Shock Alive
10 26/F Massive 1.342 1 2.4 3.3 Shock Alive
11 56/M Massive 0.08 1.5 1.4 4.0 Shock Alive
12 32/F Massive 1.244 2 1.2 2.8 Shock Alive
13 83/M Massive < 0.02 2.2 1.0 1.4 Shock Alive

CPR cardiopulmonary resuscitation, CT computed tomography, ECMO veno-arterial extracorporeal membrane oxygenation, F female, LMWH low-molecular-weight heparin, M male, PE pulmonary embolism, RV/LV right-to-left ventricular, UFH unfractionated heparin